Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie
PubMed
33621713
PubMed Central
PMC7896113
DOI
10.1016/j.ajogmf.2021.100329
PII: S2589-9333(21)00024-0
Knihovny.cz E-zdroje
- Klíčová slova
- coronavirus, coronavirus disease 2019, infection, pregnancy, severe acute respiratory syndrome coronavirus 2,
- MeSH
- COVID-19 * MeSH
- infekční komplikace v těhotenství * diagnóza MeSH
- jednotky intenzivní péče o novorozence MeSH
- lidé MeSH
- novorozenec MeSH
- retrospektivní studie MeSH
- SARS-CoV-2 MeSH
- těhotenství MeSH
- výsledek těhotenství * epidemiologie MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- Geografické názvy
- Asie MeSH
- Austrálie MeSH
- Evropa MeSH
- Jižní Amerika MeSH
BACKGROUND: It has still to be ascertained whether severe acute respiratory syndrome coronavirus 2 infection in pregnancy is associated with worse maternal and fetal outcomes compared to low risk gestations. OBJECTIVE: This study aimed to evaluate maternal and perinatal outcomes in high- and low-risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection. STUDY DESIGN: This was a multinational retrospective cohort study involving women with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection from 76 centers from 25 countries in Europe, the United States, South America, Asia, and Australia from April 4, 2020, to October 28, 2020. The primary outcome was a composite measure of maternal mortality and morbidity, including admission to the intensive care unit, use of mechanical ventilation, or death. The secondary outcome was a composite measure of adverse perinatal outcome, including miscarriage, fetal loss, neonatal and perinatal death, and admission to the neonatal intensive care unit. All outcomes were assessed in high- and low-risk pregnancies. Pregnancies were considered high risk in case of either preexisting chronic medical conditions in pregnancy or obstetrical disorders occurring in pregnancy. The Fisher exact test and logistic regression analysis were used to analyze the data. RESULTS: A total of 887 singleton pregnancies who tested positive for severe acute respiratory syndrome coronavirus 2 infection using reverse transcription-polymerase chain reaction of nasal and pharyngeal swab specimens were included in the study. The risk of composite adverse maternal outcomes was higher in high-risk pregnancies than in low-risk pregnancies (odds ratio, 1.52; 95% confidence interval, 1.03-2.24; P=.035). In addition, women carrying high-risk pregnancies were at higher risk of hospital admission (odds ratio, 1.48; 95% confidence interval, 1.07-2.04; P=.002), presence of severe respiratory symptoms (odds ratio, 2.13; 95% confidence interval, 0.41-3.21; P=.001), admission to the intensive care unit (odds ratio, 2.63; 95% confidence interval, 1.42-4.88), and invasive mechanical ventilation (odds ratio, 2.65; 95% confidence interval, 1.19-5.94; P=.002). When exploring perinatal outcomes, high-risk pregnancies were at high risk of adverse perinatal outcomes (odds ratio, 1.78; 95% confidence interval, 0.15-2.72; P=.009). However, such association was mainly because of the higher incidence of miscarriage in high-risk pregnancies compared with that in low-risk pregnancies (5.3% vs 1.6%, P=.008); furthermore, there was no difference in other explored outcomes between the 2 study groups. At logistic regression analysis, maternal age (odds ratio, 1.12; 95% confidence interval, 1.02-1.22; P=.023) and high-risk pregnancy (odds ratio, 4.21; 95% confidence interval, 3.90-5.11; P<.001) were independently associated with adverse maternal outcomes. CONCLUSION: High-risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection were at higher risk of adverse maternal outcomes than low-risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection.
ABC Medical Center Mexico City Mexico
Alexandra Hospital National and Kapodistrian University of Athens Athens Greece
Alvaro Cunqueiro University Hospital of Vigo Vigo Spain
Assistência Obstétrica do Grupo Perinatal Rio de Janeiro Brazil
Batman Maternity and Child Health Hospital Batman Turkey
Bursa City Hospital Bursa Turkey
Campus Bio Medico University of Rome Rome Italy
Cengiz Gokcek Women's and Children's Hospital Gaziantep Turkey
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno Buenos Aires Argentina
Clínica del Country Bogotá Colombia
Community Medical Centers University of California San Francisco Fresno Fresno CA
Departamento de Ginecologia e Obstetrícia Hospital Universitário Polydoro Ernani Santiago Brazil
Departamento De Ginecologia Y Obstetricia Centro Medico La Paz De Bata Bata Guinea Ecuatorial
Department Gynecology and Obstetrics Fornaroli Hospital Magenta Italy
Department of Anaesthesia Lyell McEwin Hospital Adelaide Australia
Department of Neonatology Obstetrics and Gynecology University Hospital Sofia Bulgaria
Department of Obstetrics and Gynecology Hasanuddin University Makassar Indonesia
Department of Obstetrics and Gynecology Sanko University School of Medicine Gaziantep Turkey
Department of Obstetrics and Gynecology Sant'Anna Hospital University of Turin Turin Italy
Department of Obstetrics and Gynecology University of Dicle Diyarbakır Turkey
Department of Obstetrics and Gynecology University of Parma Parma Italy
Department of Perinatal Medicine Memorial Hospital Istanbul Turkey
División Obstetricia Hospital de Clínicas José de San Martín Buenos Aires Argentina
Division of Neonatology Hospital Clínico San Carlos Madrid Spain
Düzce University Medicine Faculty Department of Perinatology Düzce Turkey
Fetal Medicine Unit Di Venere Hospital Bari Italy
Hisar Intercontinental Hospital Instanbul Turkey
Hospital Angeles Lomas Mexico City Mexico
Hospital Clinico San Jose Chile Santiago Chile
Hospital Juan A Fernandez Buenos Argentina
Hospital Raul F Larcade Buenos Aires Argentina
Hospital Regional Universitario de Málaga Malaga Spain
Hospital Universitari Germans Trias i Pujol Barcelona Spain
Hospital Universitario de Móstoles Mostoles Spain
Hospital Virgen De La Luz Cuenca Spain
Instituto de MedFetal e Diagnóstico por Imagem do Amazonas Manausi Brazil
Instituto Nacional Materno Perinatal Lima Peru
Karaman Public Hospital Karaman Turkey
KBC Dr Dragisa Misovic Dedinje Belgrade Serbia
National Medical Research Center for Obstetrics Gynecology and Perinatology Moscow Russia
Ospedale Generale Regionale F Miulli Acquaviva delle Fonti Italy
Ostetricia e Ginecologia Universitaria Ospedale S Anna e S Sebastiano Caserta Italy
Perinatal Medicine Foundation Department of Perinatal Medicine Memorial Hospital Istanbul Turkey
Regional Hospital Gjakova Kosovo Republic of Kosovo
Sakarya University Education and Research Hospital Sakarya Turkey
Servicio de Obstetricia y Ginecología Hospital Universitario y Politécnico La Fe Valencia Spain
Sulochana clinic Kolkata India
Unit of Obstetrics and Gynecology Ospedale Maggiore Bologna Italy
Universitatea de Medicină și Farmacie Grigore T Popa Iași Iasi Romania
University Clinic Hospital of Valladolid Valladolid Spain
University Clinic of Obstetrics and Gynecology Skopje North Macedonia
University Hospital of Obstetrics and Gynecology Sofia Bulgaria
University Of Health Sciences Umraniye Training And Research Hospital Turkey Istanbul
Zobrazit více v PubMed
Perlman S. Another decade, another coronavirus. N Engl J Med. 2020;382:760–762. PubMed PMC
World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Available at: https://covid19.who.int/. Accessed 26 October 2020.
Centers for Disease Control and Prevention . 2021. Data on COVID-19 during pregnancy: birth and infant outcomes.https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/special-populations/birth-data-on-covid-19.html Available at: Accessed December 2020.
Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2 PubMed PMC
WAPM (World Association of Perinatal Medicine) Working Group on COVID-19 Maternal and perinatal outcomes of pregnant women with SARS-COV-2 infection. Ultrasound Obstet Gynecol. 2020;57:232–241. PubMed
Di Mascio D, Sen C, Saccone G, et al. Risk factors associated with adverse fetal outcomes in pregnancies affected by coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19. J Perinat Med. 2020;48:950–958. PubMed
Huntley BJF, Huntley ES, Di Mascio D, Chen T, Berghella V, Chauhan SP. Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection: a systematic review. Obstet Gynecol. 2020;136:303–312. PubMed
Dubey P, Reddy SY, Manuel S, Dwivedi AK. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: an updated systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:490–501. PubMed PMC
Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020;56:15–27. PubMed PMC
Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. PubMed PMC
Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. PubMed PMC
World Health Organization . 2020. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected.https://www.who.int/publications/i/item/10665-332299 Available at: Accessed December 2020.
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. PubMed PMC
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. PubMed PMC
Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med. 2020;17 PubMed PMC
Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. PubMed PMC
CDC COVID-19 Response Team . Vol. 69. 2020. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020; pp. 382–386. (MMWR Morb Mortal Wkly Rep). PubMed PMC
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. PubMed PMC
Cunningham JW, Vaduganathan M, Claggett BL, et al. Clinical outcomes in young US adults hospitalized with COVID-19. JAMA Intern Med. 2020 [Epub ahead of print] PubMed PMC